QP Release
Product Description
Eramol
-
Country/Region:United Kingdom
-
On CPHI since:2026
-
Certificates:4
-
Employees:25 - 49
Company types
Primary activities
Categories
Specifications
Eramol
-
Country/Region:United Kingdom
-
On CPHI since:2026
-
Certificates:4
-
Employees:25 - 49
Company types
Primary activities
More Products from Eramol (4)
-
Product Non Sterile Manufacturing
Oral dosage forms (tablets, capsules, oral liquids)Actives and placebos -
Product Packaging & Labelling
Primary and Secondary packaging and labelling capabilities -
Product Sterile Fill Finish
Aseptic and Terminal sterilisationsmall moleculelarge molecule/biologicsADCsATMPSCell & Gene TherapyPeptidesOligonucleotidesRadiopharmaViral Vectors -
Product Storage & Distribution
Storage and global distribution capabilities
Eramol resources (1)
-
News New Sterile Manufacturing Facility (End to End CMO service)
Eramol’s new sterile manufacturing facility at its Sevenoaks campus is a purpose-built, EU GMP Annex 1 aligned site designed to support early-phase sterile injectable programmes. The facility features isolator-based aseptic fill-finish and terminal sterilisation, with phase-appropriate batch sizes and a strong focus on sterility assurance and product protection, achieving <1% line losses. Fully integrated with Eramol’s wider services, the facility provides an end-to-end sterile solution including packaging and labelling, QC testing, UK/EU QP release, regulatory support, GMP/GDP storage and global distribution, with planned expansion to support later-stage and commercial manufacturing.